Adlai Nortye (NASDAQ: ANL) narrows loss and builds US$231.9M cash in H1 2026
Adlai Nortye (NASDAQ: ANL) reported a narrowed net loss of US$5.3 million in the first half of 2026, a significant improvement from US$18.3 million a year prior, primarily due to new collaboration revenue from its AN9025 license agreement. The clinical-stage oncology company also substantially …